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There is ample historical veriﬁcation of 46,XX congenital adrenal hyperplasia (CAH) patients being born with essentially male
genitaliawhile outcome information is scant. Prior to glucocorticoid therapy, most patients died very young from adrenal
insuﬃciency. Most available reports from laterchildhood, contain little information concerning sexual identity. Reports on older
individuals lack adequate information about sexual identity and quality of life. The diﬃculty in assessing the relative impact of
multiple dynamic environmental factors on the development of sexual identity, self- and body esteem and overall adjustment to
life is clear. Nevertheless, it remains unclear whether those infants whose masculine genitalia at birth resulted in an initial male
assignment would have enjoyed a better adult outcome had they been allowed to remain male rather than the female reassignment
that most received. Further, one could ask whether a male sex of rearing should be considered in 46,XX CAH infants with male
external genitalia. After reviewing available literature, we conclude that because those extremely virlized 46,XX CAH patients who
were reared male with healthy social support demonstrated satisfactory levels of social and sexual function as adults a male sex
assignment should be considered in these types of infants when social and cultural environment are supportive.
1.Background
The virilizing forms of 21-hydroxylase and 11-hydroxylase
deﬁciency CAH manifest a complete spectrum of viriliza-
tion in 46,XX individuals ranging from none to complete
virilization such that in rare cases the external genitalia
are entirely male with absent testes. When this diagnosis
of CAH is recognized in infancy, the recommendation for
sex of rearing—even in those with fully virilized external
genitalia—has been categorically female. The support for
this dogmatic approach revolves around the preservation of
fertility; that is, because there are ovaries and a uterus, a
female assignment is justiﬁed. This recommendation stems
from the outcome data that show that with appropriate
therapy, normal female growth, development, and fertility,
and, a female sexual identity can be reasonably anticipated
with a female sex assignment. However, these outcome data
have also been disappointing in some respects, particularly
in those who were markedly virilized at birth [1, 2]. It is
important to point out the similarities of this reasoning
to the rationale present in the optimal gender approach
used beginning in the 1950’s to guide sex assignment in
DSD infants. Although almost all (∼95%) 46,XX CAH
infants develop a female gender identity as adults, a sizable
number have diﬃculty establishing intimate relationships
and fertility is markedly reduced [3, 4]. While gender role
behavior and sexual orientation should not be considered
as evidence of treatment failure, a larger portion of these
CAH patients are homo- or bisexual compared with the
generalpopulation [5]. The roleplayed by prenatalandrogen
exposure on the developing brain and its relationship to
outcomes in CAH patients remains unclear, but the evidence2 International Journal of Pediatric Endocrinology
supporting a relationship between androgen and brain
development is irrefutable [5]. The available outcome data
on sexual identity in 46,XX CAH patients cited throughout
this paper suggests that it may be related to the variable
degrees of virilization of the external genital seen in this
disorder, and it is therefore counterintuitive to propose that
all 46,XX CAH infants be managed identically regardless of
degree of genital virilization.
While rare, the percentage of 46,XX patients with CAH
born with Prader 4-5 genitalia is unknown, and it would
be expected to occur more commonly in those patients
harboring mutations causing severe enzyme deﬁciency.
Further, since reports of gender assignment do not clearly
indicate what portion were born with Prader 4-5 genitalia,
the historical percentage of this subgroup of CAH infants
who are reared male versus female is unknown. Further,
it is impossible to ascertain surgical histories. However,
since this surgical history is both incomplete and likely
not representative of modern surgical approaches history, it
should have little bearing on considerations for the future
care. Using modern surgical techniques, virilized 46,XX
CAH infants would need only one procedure to remove
internal structures, correct hypospadias/chordee, and to
place prosthetic testes if desired.
In this report, we attempt to separate this unique group
of virilized CAH infants and present what is known about
their outcomes. In the last year, we have reported our
experience with a group of 46,XX male CAH patients. This
report described 12 adult 46,XX CAH males, all of whom
have a male gender identity and were sexually attracted
to females, 10 of whom had always been reared male,
as well as a group of four 46,XX infants whose parents
chose a male sex assignment (after full disclosure) even
after the diagnosis of CAH in the neonatal period. It was
during the preparation of the paper about the 12 adult
CAH males [6] that we found extensive literature regarding
other similar patients and decided to prepare this review.
This literature review included searching for information on
severely virilized 46,XX CAH patients on PubMed, general
internet, and traditional library searches, old and current
endocrinology textbooks, followed by locating references of
earlier publications cited in located publications.
2. LiteratureReview
Historically, the diagnosis of CAH in those rare individuals
with Prader 4 or 5 external genitalia has been delayed in
spite of clinical evidence of adrenal crisis (Table 1)[ 7].
Especially prior to the availability of glucocorticoid therapy,
the diagnosis was often made at autopsy following a death
from adrenal insuﬃciency [8]. In others, the diagnosis
of CAH was made during the assessment of presumed
cryptorchidism, gynecomastia, or hematuria. Previously it
was recommended that these patients be reassigned female
when the diagnosis was made during childhood. More
recently, however, it has been recognized that gender identity
appears to be established in the ﬁrst several years of life [9]
and that gender reassignment may be harmful. This practice
has provided a smallgroup of 46,XX CAH adultmales whose
quality of life can now be assessed.
Those patients listed in Table 1 include patients whose
genitalia were essentially male at birth, having fully fused
labia with the penile urethra being at the tip of the glans
or distally on the underside of the penis (Prader stage 4 or
5). While there are several reports, these are essentially case
reports and do not involve systematic assessment of subjects
but rather descriptions of presentation and natural history.
Many details are lacking, particularly regarding evidence
of gender dysphoria. Hence, it is impossible to clearly
substantiate outcome data. Table 1(a) consists of patients
who died from adrenal insuﬃciency in infancy. Table 1(b)
lists those reared male but reported during childhood so
that long-term outcome data are not available. Table 1(c)
lists patients reassigned female including some for whom
outcome data is known. Table 1(d) includes patients reared
male who were reported during adulthood; within this later
group are the most informative outcome data summarized
below. The attempt is to review outcome information, with
a focus on outcomes in patients born with male genitalia,
requiring little to no genital surgery. There are additional
reports of patients born with genital ambiguity who had
gender dysphoria who declared a male gender in adulthood.
This later group constitutes a diﬀerent situation than the
sexual identity issues seen in the nonambiguous primary
group reported here.
3. Review of Recommendation for
Gender Assignment
The standard of care for 46,XX CAH patients diagnosed in
infancy has been to recommend a female gender assignment
and sex of rearing. This standard is based on the idea that
these patients are really female—as deﬁned by karyotype—
and the beneﬁt of preserving fertility outweighs a small risk
of future gender dysphoria or dysfunctional sexual function
resulting from surgery. The expectation has been that, with
appropriate medical care of adrenal hyperplasia, growth,
puberty, sexuality, and reproduction would be similar to
unaﬀected females. Historically, even 46,XX CAH patients
with male external genitalia were felt to have a reasonable
expectation of fertility. However, while fertility rates in many
46,XX CAH patients are only slightly impaired, the fertility
rate of severely virilized CAH patients is strikingly low
[3]. This generation of patients also underwent feminizing
surgery that often damaged the neurovascular supply of
the external genitalia, thereby precluding normal sexual
responsiveness. While it is hoped that modern surgical
techniques reduce the risk of neurovascular damage, it is
likely that other factors also inﬂuence sexuality and fertility
in these patients.
In the case of the fully virilized 46,XX CAH patient, a
male sex of rearing minimizes the need for external genital
surgery (other than placement of prosthetic testes), and the
outcome in these patients showing suﬃcient male sexual
function suggests that satisfactory adult sexual activity is
possible. Given the high rates of male gender identity andInternational Journal of Pediatric Endocrinology 3
Table 1: 46,XX∗ CAH patients with male external genitalia assigned/reared male.
(a) Death during infancy, most with evidence of adrenal insuﬃciency.
Year First author Reference
(1) 1896 Krokiewicz
Virchow’s Arch path Anat Physiol
146:525
(2) 1905 Fibiger Virchow’s Arch path Anat 181:1
(3) 1914 Benda Berlin klin. Wschr 51:66
(4) 1919 Lehmann Ugesk. Laeger 81:751
(5) 1947 Allibone Arch Dis Child 22:210
(6) 1952 Marie Arch franc pediat 9: 785
(7) 1953 Perloﬀ J Clin Endocrinol 13:78
(8) 1954 Matheson Arch Dis Child 29:22
(9) 1961 Rook Am J Dis Child 101:645
(b) Diagnosed and reported during childhood, reared male.
Year First author Reference Age of diagnosis
(1) 1955 Gross Pediatrics 16:303 ?
(2) 1956 Bentinck J Clin Endocrinol Metab 16:412 2 years
(3) 1957 Wilkins Dx and Rx of Endocrine Disorders, 2nd 7.5 years
(4) 1958 Prader Helv Paediatr Acta 13:5 4 years
(5) 1966 Weldon N Engl J Med 274:829 2.5 years
(6) 1966 Weldon N Engl J Med 274:829 3.5 years
(7) 1972 Redman J Urol 108:500 6 years
(8) 1976 Money J Homosex 1:357 1m o n t h
(9) 1976 Money J Homosex 1:357 12 years
(10) 1970 Gillenwater J Urol 103:500 4 years
(11) 1987 Wyatt J Pediatr Endocrinol 2:35 3.6 years
(12) 1984 R¨ osler Adrenal Disease in Childhood 13:47 1.9 years
(13) 1984 R¨ osler Adrenal Disease in Childhood 13:47 1 year
(14) 1984 R¨ osler Adrenal Disease in Childhood 13:47 1.6 years
(15) 1984 R¨ osler Adrenal Disease in Childhood 13:47 2 years
(16) 1989 Chan-Cua Amer J Med Genetics 34:406 8.2 years
(17) 1989 Chan-Cua Amer J Med Genetics 34:406 4.3 years
(18) 1997 Sripathi Brit J Urol 79:785 10 years
(19) 1997 Sripathi Brit J Urol 79:785 4 years
(20) 1997 Sripathi Brit J Urol 79:785 7 years
(21) 1997 Sripathi Brit J Urol 79:785 11 years
(22) 1997 Sripathi Brit J Urol 79:785 3.5 years
(23) 1997 Sripathi Brit J Urol 79:785 16.6 years
(24) 2002 Woelﬂe Clin Endocrinol 56:231 3.5 years
(25) 2002 Woelﬂe Clin Endocrinol 56:231 4.5 years
(26) 2002 Woelﬂe Clin Endocrinol 56:231 7 years
(c) Diagnosed during infancy or childhood with reassignment.
Year First author Reference Age of reassignment
(1) 1958 Ainger AMA J Dis Child 95:410 3 years
(2) 1965 Wiedemann Monatsschr Kinderheilkd 113:434 14 months4 International Journal of Pediatric Endocrinology
(c) Continued.
Year First author Reference Age of reassignment
(3) 1966 Weldon N Engl J Med 274:829 3w e e k s
(4) 1966 Weldon N Engl J Med 274:829 8w e e k s ∗∗
(5) 1966 Weldon N Engl J Med 274:829 11 months
(6) 1969 Rosenberg N Eng J Med 280:131 3w e e k s
(7) 2002 Woelﬂe Clin Endocrinol 56:231 2d a y s
(8) 2002 Woelﬂe Clin Endocrinol 56:231 1m o n t h
(9) 2002 Woelﬂe Clin Endocrinol 56:231 1m o n t h
(10) 2002 Woelﬂe Clin Endocrinol 56:231 1m o n t h
(11) 2002 Woelﬂe Clin Endocrinol 56:231 1m o n t h
(12) 2002 Woelﬂe Clin Endocrinol 56:231 19 months
(13) 2002 Woelﬂe Clin Endocrinol 56:231 7 years
(14) 2002 Woelﬂe Clin Endocrinol 56:231 9 years
(15) 2002 Woelﬂe Clin Endocrinol 56:231 11 Years
(16–24) 2006 Gupta Pediatr Surg Int 22:905 not stated
(d) Diagnosed during childhood, reared male, reported >17 years.
Year First author Reference Age at report
(1) 1960 Peris Obstet Gynecol 16:156 18 years
(2) 1963 Madsen J Urol 90:446 35 years
(3) 1963 Madsen J Urol 90:446 30 years
(4) 1965 Maxted J Urol 94:266 21 years
(5) 1976 Money J Homosex 1:357 adult
(6) 1976 Money J Homosex 1:357 adult
(7) 1978 Kiviat Urol 12:75 17 years
(8–15) 1984 R¨ osler Adrenal Disease in Childhood 13:47 17–33 years
(16) 2002 Woelﬂe Clin Enocrinol 56:231 36 years
(17) 2002 Woelﬂe Clin Enocrinol 56:231 31 years
(18) 2002 Woelﬂe Clin Enocrinol 56:231 50 years
(19) 2002 Woelﬂe Clin Enocrinol 56:231 24 years
(20) 2004 Jones J Pediatr Endocrinol Metab Died at 31 years
(21) 2010 Lee J Urol 184 (suppl 4):1786 35 years
(22) 2010 Lee J Urol 184 (suppl 4):1786 36 years
(23) 2010 Lee J Urol 184 (suppl 4):1786 45 years
(24) 2010 Lee J Urol 184 (suppl 4):1786 46 years
(25) 2010 Lee J Urol 184 (suppl 4):1786 47 years
(26) 2010 Lee J Urol 184 (suppl 4):1786 49 years
(27) 2010 Lee J Urol 184 (suppl 4):1786 49 years
(28) 2010 Lee J Urol 184 (suppl 4):1786 53 years
(29) 2010 Lee J Urol 184 (suppl 4):1786 57 years
(30) 2010 Lee J Urol 184 (suppl 4):1786 69 years
∗for those reported before the ability to determine the presence of an XX karyotype; this karyotype is presumed based upon the presence of diﬀerentiation
consistent with this, either from autopsy ﬁndings or surgical observations.
∗∗t h o s ew i t hr e p o r t e dg e n d e rp r o b l e m s .
sexual orientation toward females in 46,XX CAH patients
assigned male—with appropriate family support—we pro-
pose that it is reasonable to consider a male sex of rearing
in the markedly virilized 46,XX CAH patient, even when
diagnosed in the neonate. To support this proposal, outcome
information from markedly virilized patients reared male
will be reviewed. As noted, early reports often involved
patients who died in infancy or childhood due to adrenalInternational Journal of Pediatric Endocrinology 5
insuﬃciency [8]. In others, the diagnosis was made after
the child had ﬁrmly established a male gender identity
and reassignment was not considered. It is from this small
group of 46,XX CAH adult males (Table 1(d)) that outcome
information is particularly informative.
4. ReportofGenderOutcome,IncludingbutNot
LimitedtoThose FullyMasculinized
In 2005, a literature review of gender identity, gender change
and gender dysphoria in 46,XX CAH patients included 250
subjectswithvaryingamountsofmasculinizationofexternal
genitalia reared female and 33 subjects with male genitalia
reared male [10] .A g ea tl a t e s tr e p o r tr a n g e df r o m4t o4 9
years. Initial sex assignment is not clear for all of the 250
reared female, 24 of whom were initially assigned male.
In those 24 initially assigned male, female reassignment
occurred in the ﬁrst 19 months of life for 20 and the
remaining 4 were reassigned female between the ages of
3.5 and 9 years of age. Of these 250 reared female, 4 were
subsequently reassigned male, including 2 who had been
assigned male at birth. A total of 13 had gender dysphoria,
including all of the patients reassigned male. Dysphoria was
not present in 232 and was not reported for 15. Hence,
among 235, 222 or 94.4% had a female gender identity with
no gender dysphoria. Gender identity problems were found
in 4.6%, a higher percentage than the 0.008% found in one
country, which may not be representative of the general
population [11].
Among the 33 who were initially assigned and reared
male, gender dysphoria was found in 4 or 12%. One had
gender dysphoria, one had a “disturbed gender identity”, one
was ambivalent, and one was not adjusted as a male. These
4 ranged in age from 17 to 49 years. While the percentages
diﬀer, there simply are inadequate data to conclude that
there is a diﬀerence regarding gender problems among CAH
patients reared male or female. It is noteworthy that gender
problems were reported only for those over 17 years of age,
forming the rationale for our focus on subjects aged 17 years
or older.
This report illustrates the complexities of attempting to
make meaningful conclusions because degree of virilization,
ageofgenderassignmentandreassignment,andevidencefor
gender dysphoria were not systematically assessed. Among
the 13 of the 250 reared female reported to have gender
dysphoria, severity of masculinization at birth was not
indicated for 5, and initial gender assignment was female for
7. Many of these 250 females were born with lesser degrees
of genital virilization in contrast to the 33 subjects initially
assigned and reared male, all of whom had essentially male
genitalia. Further, gender dysphoria was reported among
those of all ages, while gender dysphoria manifest during
adulthood is probably stronger evidence. While the authors’
conclusion [10] was that there was no basis for a gender
assignment other than female for all CAH 46,XX patients,
the two groups, those reared female and male, are not
comparable given their diﬀerent numbers, age at assessment,
and spectrum of masculinization.
5. Small Series of Outcome Information
While the authors of the above report conclude that the
generalpolicyofassigningseverelymasculinized46,XXCAH
patients female is justiﬁed, we would disagree based on the
fact that the outcome data, which did not consistently report
the degree of virilization, was insuﬃcient to allow the degree
of virilization to be compared with the outcome measures
used. To be fair, we do not feel that this report presents
enough data to recommend a male assignment either.
However, the following citations of available adult outcome
data, although scant, are adequate to suggest male gender
identity, satisfactory sexual function, and an expectation of
sexual orientation toward females in those severely virilized
46,XX CAH patients who were assigned male. These factors
together with the diﬀerences in the extent and consequences
(fertility, sexual function) of surgical repair required for
female assignment need to be considered when making the
decision to raise a child in the male or female sex.
5.1. Age and Determinants of Gender Components. It is of
interest that fully virilized 46,XX CAH individuals develop
an apparently clear male gender identity during infancy,
at the age when gender identity is expected to occur [9].
However, the relative inﬂuence of other factors, including
prenatal androgen exposure [12] and other cultural inﬂu-
ences, including being treated by parents and others as a
male, remains unclear [13].
Although correlative animal studies suggest that neu-
roendocrine mechanisms of diﬀerentiation of neural circuits
are involved in sexual partner preference (sexual orienta-
tion), applicability to human gender identity and sexual
orientation is unclear [14]. Prenatal and neonatal brain
exposure to androgens may play a role in human sexual
behavior, no impact on gender identity is known. In fact,
evidence suggests that the initial gender assignment remains
the best indicator of adult gender identity [15], a factor that
must be considered for the markedly virilized 46,XX CAH
patient assigned male.
6. Reports Vary by Age and Completeness of
Assessment
Further review of reports of those with essentially complete
male virilization includes the several studies that report
subjects less than 17 years of age: two at 3.5 years of age
and 12 years of age [16], another two 46,XX Prader 5
patients reared male without gender problems who were
diagnosed during evaluation for cryptorchidism [7], six
patients (including 2 brothers) diagnosed at birth but reared
as male at parents insistence, who had no recognized
evidence of gender problems at ages 3 to 16 years [17], and
3 Prader 5 patients assigned male continued to live as males
when reported (aged 11–16 years) with one who expressing
concern about “living as a male” [18].
In a series from Saudi Arabia, 6 of 51 46,XX CAH
children underwent gender reversal and were managed as
males [16]. The choice was based primarily on parents’6 International Journal of Pediatric Endocrinology
input, with 4 of the 6 having delayed diagnosis. All had
gonadectomy and excision of M¨ ullerian-derived structures;
2 received circumcision/hypospadias repair and 4 underwent
c h o r d e er e p a i r .A l lw e r er e p o r t e dt ob ew e l la d j u s t e dt ot h e i r
sexual status with normal male behavior and activities but
none were adults, all aged between 3 to 16 years. Further,
it is unclear if any were fully masculinized. This report
likely reﬂects cultural diﬀerences in attitudes about gender
and sexuality, the role of the sexes in society, and parents’
perceptions.
Adult patients (>17 years) included one reared male
with Prader 4 genitalia before glucocorticoid therapy and
without surgery who had a clear male gender identity,
sexual orientation toward females, and an intimate sexual
relationship [19], another adult patient who had always lived
as a male with no gender issues [20] ,a n df o u rP r a d e r5
patients originally assigned male who continued to live as
males without gender problems (aged 31 to 50 years) [17].
One of these subjects was married and another denied ever
having a sexual experience with a partner. For the remainder
of those listed in Table 1(d), outcome adjustment is not
indicated beyond the fact that they were male.
7. Fully MasculinizedAdult Patients
Assigned/RearedMale
Among twenty adult patients reared male, brief comments
were included for 3 with gender problems (Table 1(d)-1–
20). In addition, we have added ten more 46,XX males,
aged 35 to 69 years of age who have always lived as male
[6]. These men are all prescribed calculated replacement
glucocorticoid therapy to provide adequate therapy for daily
glucocorticoid needs and suppress sex steroid excess and
have been also prescribed replacement testosterone therapy.
Althoughsomeofthesemenhavehadsigniﬁcantadjustment
issues and poor family support, all retain a male gender
identity with a sexual orientation toward females; 8 were
married or had long-term female partners. Thus, while these
men were not uniformly assessed, brief comments regarding
gender problems or unknown severity were noted in 3 of the
30.
While gender change from female to male has been
documentedin46,XXCAHpatients[21],theauthorsarenot
aware of any instance of gender change from male to female
in this group of patients. The available outcome data are
not suﬃciently complete to allow comparison of outcomes
between fully masculinized 46,XX CAH patients reared male
versus those reared female, and it is unlikely that such data
will be available in the near future given the complexity
of the factors needed to accurately assess outcome. The
relationship between gender identity and quality of life has
not been adequately studied in such situations. Reports of
quality of life among chronically ill older patients report
inconsistent ﬁndings regarding the relationship of quality
of life and gender role [22, 23], while it is clear that those
with gender identity disorders have signiﬁcant quality-of-
life issues [24, 25]. However, in this situation, there may
not be gender dysphoria. Further, it is quite possible that
quality of life for the virilized 46,XX CAH patient proceeds
from the initial gender assignment, providing the basis for a
secure gender identity. This may provide a crucial factor in
quality of life. This is consistent with a stable gender identity
beinganimportantfactorinqualityoflife.Fortunately,there
is some agreement on those outcome factors that should
be used to judge quality-of-life outcomes for 46,XX CAH
patients: self esteem, body image, fulﬁlling interpersonal
relationships, harmonious sexual identity (gender identity,
sexual experience satisfaction), and fertility. When these
factors are measured in 46,XX CAH patients assigned male,
the outcome is comparable to those assigned female. In this
lattergroup,thosewhoweremostvirilizedoftenmanifestthe
worst outcomes.
Hence, we feel that a male gender assignment for the
severely virilized patient is worthy of consideration and
are advocating for this [26]. Further, we feel the available
data provide some compelling reasons to consider a male
assignment in some of the severely virilized 46,XX CAH
subjects.
Furthermore, we believe that these specialized cases of
46,XX DSD have something to say about gender assignment
in general and for those diﬃcult cases of 46,XY DSD. When
considering gender assignment, many factors must be taken
into consideration. It would be incorrect to assign gender
based upon the presumed dictates of biological variables
alone. What needs to be done as illustrated by the cases
herein is to weigh all the factors with a focus on what
assignment would hopefully provide the best quality of life
in the long run.
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